DEBBANE RAYMOND 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Jun 3, 2025
Insider Transaction Report
Form 4
DEBBANE RAYMOND
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-03+103,806→ 103,806 totalExercise: $0.62Exp: 2035-06-03→ Common Stock (103,806 underlying) - Award
Restricted Stock Units
2025-06-03+89,312→ 89,312 totalExercise: $0.00→ Common Stock (89,312 underlying)
Footnotes (3)
- [F1]Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date.
- [F2]Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock.